Real-time data

Listing exchange

NASDAQ Stock Exchange

Price

$3.9

Day High

$3.96

Day Low

$3.8

Day Open

$3.84

Volume

6195

Day Change

3.33%

Latest news data for ABOS

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2022 Financial Results on March 27, 2023

Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum

BMEZ CEF: Significant Risks Remain (NYSE:BMEZ)

Acumen Pharmaceuticals: An Alzheimer's 'Lottery Ticket' (NASDAQ:ABOS)

Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell on Q3 2022 Results - Earnings Call Transcript

Acumen Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:ABOS)

Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer's Disease

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update

Acumen Pharmaceuticals Shares Rise After FDA Designation

These Are the Five Best and Worst Performing Small-cap Stocks in September 2022 – 24/7 Wall St.

News sentiment (24 hrs)

Intraday data

Historical data

maximum of 5 years displayed, 40+ years of data available via API